Influence of Body Mass Index and Gender on Growth Hormone (GH) Responses to GH-Releasing Hormone Plus Arginine and Insulin Tolerance Tests
Authors:
- 1 March 2005
- journal article
- clinical trial
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 90 (3) , 1563-1569
Abstract
The aim of this study is to assess whether gender and body mass index (BMI) should be considered in developing thresholds to define GH deficiency, using GH responses to GHRH + arginine (ARG) stimulation and insulin tolerance test (ITT). Thirty-nine healthy subjects (19 males, 20 females; ages 21–50 yr) underwent GHRH + ARG, and another 27 subjects (19 males, 8 females; ages 20–49 yr) underwent ITT. Peak GH response was significantly higher (P = 0.005) after GHRH + ARG than with ITT, and this difference could not be explained by age, gender, or BMI. Peak GH response was negatively correlated with BMI in both tests (GHRH + ARG, r = −0.76; and ITT, r = −0.65). Peak GH response to GHRH + ARG was higher in females than males (P = 0.004; ratio = 2.4), but it was attenuated after eliminating the influence of BMI (P = 0.13; ratio = 1.6). No significant gender differences were found in peak GH responses to ITT, which could be due to the smaller number of female subjects studied. GH response to GHRH + ARG and ITT stimulation is sensitive to BMI differences and less so to gender differences. A higher BMI is associated with a depressed GH response to both stimulation tests. BMI should therefore be considered as a factor when defining the diagnostic cut-off points in the assessment of GH deficiency, whereas whether gender should be likewise used is inconclusive from this study.Keywords
This publication has 29 references indexed in Scilit:
- Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patientsEuropean Journal of Endocrinology, 2003
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Adults and Children—2003 UpdateEndocrine Practice, 2003
- Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2002
- Effects of Aging and Estradiol Supplementation on GH Axis Dynamics in WomenThe Journal of Clinical Endocrinology & Metabolism, 2001
- Diagnosis and Management of Adult Growth Hormone DeficiencyEndocrine, 2000
- Gender differences in secretory activity of the human somatotropic (growth hormone) axisEuropean Journal of Endocrinology, 1996
- Contrasting Effects of Oral and Transdermal Routes of Estrogen Replacement Therapy on 24-Hour Growth Hormone (GH) Secretion, Insulin-Like Growth Factor I, and GH-Binding Protein in Postmenopausal Women*The Journal of Clinical Endocrinology & Metabolism, 1991
- Dual Defects in Pulsatile Growth Hormone Secretion and Clearance Subserve the Hyposomatotropism of Obesity in Man*The Journal of Clinical Endocrinology & Metabolism, 1991
- Increased hGH Production Rate after Low-Dose Estrogen Therapy in Prepubertal Girls with Turner's SyndromePediatric Research, 1990
- Premature mortality due to cardiovascular disease in hypopituitarismThe Lancet, 1990